Samsung Biologics Co LtdEigentümerstruktur
| Preis (2026-07-28) | 52W Hoch | 52W Tief |
| 1549000 KRW | 1.987.000 KRW | 1.228.000 KRW |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| - KRW | - | - | - | - | - |
| #Shares | Short [%] | Short Ratio |
| 46.290.951 | - | - |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Samsung Biologics Co Ltd
Mitarbeiter 5.195
Handelsplatz KO
Ticker Symbol 207940
IPO Datum -
Adresse 300, Songdo bio-daero, Incheon, South Korea
Webseite https://samsungbiologics.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Mr. John Chongbo Rim | CEO, President & Chairman of Board |
| 2 | Dr. Kun Lo Ph.D. | Executive VP, Head of EPCV Center & Director |
| 3 | Mr. Seung ho Ryu | EVP, CFO, Head of Business Support Center & Director |
| 4 | Mr. Pierre Catignol | Executive VP & Head of Operation Center |
| 5 | Mr. Kevin Sharp | EVP, Head of Sales & Operations Department |
| 6 | Mr. Kyuho Lee | Executive VP, Head of People Center, & Chief Human Resource Officer |
| 7 | Mr. James J. Choi | Executive VP, Head of CDO Development Center & Head of Sales Center |
| 8 | Mr. Heekyun Lim | VP & Head of Business Consulting Team |
| 9 | Sojeong Lee | VP & Head of Regulatory Affairs |
| 10 | Mr. Sangmyung Lee | VP & Head of Business Strategy |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
Für dieses Unternehmen liegen derzeit keine Daten zu institutionellen Investoren vor.